Analyst firms · Citigroup · NVRO

Citigroup NVRO price target and rating history

Nevro Corp. (NVRO) · Health Care

Citigroup rates Nevro Corp. (NVRO) Neutral with a $9 price target, as of its latest action on Aug 9, 2024. It has published 5 rating actions on NVRO since August 2021, including 2 upgrades and 3 downgrades.

Current rating
Neutral
Price target
$9
Median target, all firms
Too few
Actions on NVRO
5

Citigroup price target on NVRO

$42$25$920222023202420252026
Citigroup price target on NVRO, each point a stated target, August 2021 to May 2024. Targets before May 2024 (divided by 3) are adjusted for a stock split, going by the prior target Citigroup restated.

Every Citigroup rating on NVRO

Questions about Citigroup and NVRO

What is Citigroup's price target for NVRO?
Citigroup's latest stated price target for Nevro Corp. (NVRO) is $9, from its action on May 22, 2024.
What is Citigroup's rating on NVRO?
Citigroup rates NVRO Neutral, a neutral rating, as of Aug 9, 2024.
When did Citigroup last change its view on NVRO?
On Aug 9, 2024, Citigroup upgrades to Neutral from Sell.

More NVRO rating histories

All Citigroup ratingsNVRO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.